AlphaGenics

Alphagenics Diag is an Italian biotechnology company specializing in the development and commercialization of advanced molecular diagnostic solutions. The company focuses on providing high-quality kits for the detection of infectious diseases, genetic predispositions, and pharmacogenetic markers. Their product portfolio includes specialized assays for Human Papillomavirus (HPV) screening, thrombophilia risk assessment, and the diagnosis of hereditary conditions such as cystic fibrosis and celiac disease. By leveraging cutting-edge molecular biology techniques, Alphagenics Diag supports clinical laboratories and healthcare providers in delivering precise and timely diagnostic results. The company is headquartered in Pomezia, Italy, and maintains a strong focus on research and development to expand its diagnostic capabilities.